Nasal myiasis

 

Clinical Pathology: Nasal Myiasis (Peenash)

High-Yield Revision Notes for NEET PG / NEXT

Nasal myiasis is a parasitic infestation of the nasal cavities by the larval stage (maggots) of dipterous flies, heavily associated with poor hygiene and conditions causing a putrid odor.

Etiology & Pathogenesis

  • Primary Causative Vector: The gravid female fly of Chrysomya bezziana (Old World screwworm fly).
  • The Destructive Mechanism: Larvae possess sharp oral hooks and secrete proteolytic enzymes (including collagenases) to liquefy and devour living or necrotic tissue.
  • Classic Risk Profiles: Uncontrolled Atrophic Rhinitis (Ozaena) due to its foul odor, neglected leprosy, advanced midfacial malignancies, or comatose patients.

Clinical Progression & Complications

Initial phase presents with irritation, a crawling sensation, and sneezing. This rapidly escalates into a foul-smelling, blood-tinged serosanguinous discharge with profound facial edema.

Endoscopic exam reveals motile, whitish-creamy maggots burrowed deep into inflamed, necrotic tissue.

Anterior rhinoscopic/endoscopic view showing multiple whitish maggots with dark posterior spiracles embedded in necrotic nasal tissue
Pathological Defect Anatomical Route & Secondary Sequelae
Meningoencephalitis Larvae eat superiorly through the cribriform plate of the ethmoid bone. This grants direct access to the anterior cranial fossa, triggering purulent meningitis or localized brain abscesses.
Orbital Invasion Erosion through the thin lamina papyracea of the ethmoid bone, allowing larvae to enter the orbit and causing proptosis or absolute blindness.

Management Protocol

  1. Larval Immobilization: Instillation of a Chloroform and Turpentine oil mixture (traditionally in a 1:4 ratio) into the nasal cavity. Chloroform paralyzes the maggots, while the turpentine oil forces them to release their grip and surface.
  2. Mechanical Extraction: Meticulous extraction of maggots one by one using Tilley’s forceps or under direct nasal endoscopy.
  3. Systemic Antiparasitic Therapy: Oral or intravenous Ivermectin (200 µg/kg as a single dose) serves as a gold-standard systemic therapy to arrest larval development in deep or inaccessible sinus tracts.